Outright sale of a successful, immediate high potential, established Global presence, “no head winds” project - Contract Manufacturing Pharma Plant, (Maharashtra, India)

Posted On: 21 / Oct / 2022
1 577

Deal Details

Annual

Deal Type

Sell (Strategic Investors)
Maximum Loan

Industry

Pharmaceuticals
Charge

Deal Status

Active

Deal Description

Already established Profitable business : -

Even at 10% of Capacity, through a heady mix of export and local sales delivering 59% Gross margin and EBITDA of 20%

Clean compliant business :

No cases against the company nor Company has filed any cases.

GST and Sales Tax records are immaculate.

Pay back of 2 years approx. of capital commitment (deal value)

Currently not even utilizing 10% capacity of the Plant – if run 24 hours, potential turnover of INR 100 to 150 Million per month

Net Asset acquisition

Total Net Asset Value represent active assets which will serve as Collateral for the immediate capital acquisition value

Attached Files

icon Pharma Profile teaser deck pptx

Deal Value
45 Crore
Targeted Region
Asia Pacific

Revenue

2019-20
7 Crore
2020-21
10 Crore
2021-22
8.5 Crore